These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


775 related items for PubMed ID: 19524974

  • 21. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [Abstract] [Full Text] [Related]

  • 22. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.
    Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC.
    J Urol; 2006 Sep; 176(3):985-90. PubMed ID: 16890677
    [Abstract] [Full Text] [Related]

  • 23. Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ.
    BJU Int; 2010 Jun; 105(11):1541-7. PubMed ID: 19912191
    [Abstract] [Full Text] [Related]

  • 24. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
    Motamedinia P, Korets R, Spencer BA, Benson MC, McKiernan JM.
    Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
    [Abstract] [Full Text] [Related]

  • 25. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
    Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ.
    J Urol; 2006 Dec; 176(6 Pt 1):2453-8; discussion 2458. PubMed ID: 17085127
    [Abstract] [Full Text] [Related]

  • 26. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
    van Roermund JG, Kok DE, Wildhagen MF, Kiemeney LA, Struik F, Sloot S, van Oort IM, Hulsbergen-van de Kaa CA, van Leenders GJ, Bangma CH, Witjes JA.
    BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264
    [Abstract] [Full Text] [Related]

  • 27. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O, Eggener SE, Bianco FJ, Carver BS, Serio A, Scardino PT, Eastham JA.
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [Abstract] [Full Text] [Related]

  • 28. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [Abstract] [Full Text] [Related]

  • 29. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
    Shen S, Lepor H, Yaffee R, Taneja SS.
    J Urol; 2005 Mar; 173(3):777-80. PubMed ID: 15711268
    [Abstract] [Full Text] [Related]

  • 30. Laparoscopic extraperitoneal radical prostatectomy in complex surgical cases.
    Rodriguez AR, Kapoor R, Pow-Sang JM.
    J Urol; 2007 May; 177(5):1765-70. PubMed ID: 17437812
    [Abstract] [Full Text] [Related]

  • 31. The impact of prostate gland weight in robot assisted laparoscopic radical prostatectomy.
    Link BA, Nelson R, Josephson DY, Yoshida JS, Crocitto LE, Kawachi MH, Wilson TG.
    J Urol; 2008 Sep; 180(3):928-32. PubMed ID: 18635217
    [Abstract] [Full Text] [Related]

  • 32. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
    Freedland SJ, Grubb KA, Yiu SK, Nielsen ME, Mangold LA, Isaacs WB, Epstein JI, Partin AW.
    J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
    [Abstract] [Full Text] [Related]

  • 33. Laparoscopic radical prostatectomy and body mass index: an assessment of 151 sequential cases.
    Brown JA, Rodin DM, Lee B, Dahl DM.
    J Urol; 2005 Feb; 173(2):442-5. PubMed ID: 15643198
    [Abstract] [Full Text] [Related]

  • 34. Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins.
    Simon MA, Kim S, Soloway MS.
    J Urol; 2006 Jan; 175(1):140-4; discussion 144-5. PubMed ID: 16406892
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Percent tumor involvement and risk of biochemical progression after radical prostatectomy.
    Rampersaud EN, Sun L, Moul JW, Madden J, Freedland SJ.
    J Urol; 2008 Aug; 180(2):571-6; discussion 576. PubMed ID: 18554662
    [Abstract] [Full Text] [Related]

  • 37. Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?
    Caire AA, Sun L, Ode O, Stackhouse DA, Maloney K, Donatucci C, Mouraviev V, Polascik TJ, Robertson CN, Albala DM, Moul JW.
    Urology; 2009 Sep; 74(3):643-7. PubMed ID: 19501891
    [Abstract] [Full Text] [Related]

  • 38. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance.
    Sengupta S, Christensen CM, Zincke H, Slezak JM, Leibovich BC, Bergstralh EJ, Myers RP, Blute ML.
    J Urol; 2006 Aug; 176(2):559-63. PubMed ID: 16813889
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ, SEARCH Database Group.
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.